Strategy for treatment of fibrosis in systemic sclerosis: Present and future

The Journal of Dermatology
Koichi Yanaba

Abstract

Systemic sclerosis (SSc) is a generalized connective tissue disorder characterized by microvascular damage, autoimmunity, and excessive fibrosis of the skin and various internal organs. Regardless of the recent progress in medicine, no radical therapy for SSc has been developed, and the risk of mortality remains high. Therefore, diagnosis in the early disease stage, risk stratification for the development of serious organ involvement and therapeutic intervention with disease-modifying drugs can reduce the maximum degree of fibrosis, leading to improved long-term survival. Recently, new criteria for very early diagnosis of SSc have been proposed, which are expected to be useful for regularly following up patients with very early SSc, regardless of the absence of skin sclerosis, and for detecting the development of internal organ involvement as early as possible. At present, several immunosuppressants, including methotrexate, corticosteroids and cyclophosphamide, are being used for the treatment of fibrosis. Furthermore, mycophenolate mofetil, i.v. immunoglobulins, B-cell depletion, anti-interleukin-6 receptor antibody, autologous hematopoietic stem cell transplantation, rapamycin, pirfenidone and imatinib mesylate are potential ...Continue Reading

References

May 1, 1977·Arthritis and Rheumatism·R FleischmajerJ R Reeves
Jan 1, 1995·Trends in Pharmacological Sciences·A R ButlerD L Williams
Aug 26, 1998·British Journal of Rheumatology·S JacobsenS Ullman
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S SatoK Takehara
Jan 5, 2002·Arthritis and Rheumatism·V D Steen, T A Medsger
Aug 6, 2004·The European Respiratory Journal·T KakugawaS Kohno
Nov 3, 2004·The Journal of Clinical Investigation·Craig E DanielsEdward B Leof
Dec 2, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A Di SarioA Benedetti
Dec 14, 2004·Arthritis and Rheumatism·Naoyuki TsuchiyaShinichi Sato
Jan 11, 2005·The American Journal of Medicine·John P A IoannidisHaralampos M Moutsopoulos
Jan 26, 2005·Internal Medicine Journal·S R CoxP J Roberts-Thomson
Jun 16, 2005·Current Opinion in Pharmacology·Deborah A Young, Cheryl L Nickerson-Nutter
Aug 25, 2005·The Journal of Investigative Dermatology·Begoña SantiagoJosé L Pablos
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Aug 29, 2006·The American Journal of Pathology·Minoru HasegawaThomas F Tedder
May 24, 2007·Annals of the Rheumatic Diseases·L CzirjákG Szucs
Aug 25, 2007·American Journal of Respiratory and Critical Care Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Dec 8, 2007·Clinical Reviews in Allergy & Immunology·Norihito YazawaKunihiko Tamaki
Jul 11, 2008·Immunological Reviews·Koichi YanabaThomas F Tedder
Aug 19, 2008·Seminars in Arthritis and Rheumatism·Firas F Al-DhaherJanine M Ouimet
Jan 17, 2009·Annals of the Rheumatic Diseases·O Kowal-BieleckaUNKNOWN EUSTAR Co-Authors

❮ Previous
Next ❯

Citations

Jul 17, 2016·Best Practice & Research. Clinical Rheumatology·Kathleen MorrisroeMandana Nikpour
Aug 3, 2016·Autoimmunity Reviews·A KuhnG Bonsmann
Nov 24, 2017·Dento Maxillo Facial Radiology·Patricia Gorecki, John Rout
Jul 10, 2018·Human Vaccines & Immunotherapeutics·Christina G KatsiariLazaros I Sakkas
Aug 23, 2018·Dermatologic Therapy·Rıfkiye KüçükoğluArmağan Kutlay
Jan 2, 2019·Journal of Immunology Research·Mami ChiharaKoichi Yanaba
Aug 10, 2020·Scientific Reports·Ki-Jo KimIlias Tagkopoulos
Dec 3, 2016·Expert Review of Clinical Immunology·Cosimo BruniMarco Matucci-Cerinic
May 11, 2017·Immunologic Research·Masutaka FurueTakafumi Kadono
May 10, 2019·Inflammopharmacology·Anderson Rodrigues de AlmeidaMaira Galdino da Rocha Pitta
Jul 10, 2020·International Journal of Molecular Sciences·Daniel Feng, Casimiro Gerarduzzi
Jan 16, 2021·Clinical Reviews in Allergy & Immunology·Ming ZhaoQianjin Lu
Apr 2, 2021·Der Radiologe·Matthias Bollow
Nov 7, 2017·Immunology Letters·Marzena Ciechomska, Urszula Skalska
May 24, 2021·The Journal of Investigative Dermatology·Takashi HashimotoGil Yosipovitch
Jun 15, 2021·Inflammopharmacology·Khalil HajiasgharzadehBehzad Baradaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Endocrine, Metabolic & Immune Disorders Drug Targets
Otylia Kowal-Bielecka
International Journal of Rheumatic Diseases
Hanan Mohamed FaroukAl Hussein M El Dakrony
Polskie Archiwum Medycyny Wewnętrznej
Otylia Kowal-BieleckaKrzysztof Kowal
© 2022 Meta ULC. All rights reserved